Replies to post #409338 on Amarin Corp Plc (AMRN)

[ziploc_1]

The Amarin-Teva agreement dealt ONLY with Amarin's High Trig patent...NOT with Amarin's CVD patent....If Teva's gV is used for the CVD indication, it will be infringing once again, as it did with Teva's skinny label in the GSK case, which cost them $285 million in damages